Screening with Cost-Effective Quality Control: Potential Applications to HIV and Drug Testing
From MaRDI portal
Publication:4314920
DOI10.2307/2290923zbMath0804.62093MaRDI QIDQ4314920
Joseph L. Gastwirth, Wesley O. Johnson
Publication date: 1 December 1994
Full work available at URL: https://doi.org/10.2307/2290923
prevalence; AIDS; HIV; group testing; human immunodeficiency virus; expected cost; drug use; predictive value negative; blood screening; blood supply; infective agents; sensitivity of screening tests
62P10: Applications of statistics to biology and medical sciences; meta analysis
62Q05: Statistical tables
Related Items
Using Pooled Exposure Assessment to Improve Efficiency in Case‐Control Studies, Dual Screening, Nonparametric regression with homogeneous group testing data, A two-stage group testing model for infections with window periods, An optimal strategy for sequential classification on partially ordered sets, Dual group screening, Multinomial group testing models with incomplete identification, Informative Dorfman Screening, Bayesian inference for disease prevalence using negative binomial group testing, Multistage Group Testing Procedure (Group Screening), On Latent-Variable Model Misspecification in Structural Measurement Error Models for Binary Response, Statistical Inference Based on Pooled Data: A Moment-Based Estimating Equation Approach, Bias, efficiency, and agreement for group-testing regression models
